TAT and Wiskott-Aldrich syndrome: However, the sensitivity of genome-wide DSB detection has been reported to be relatively low when combined with the CRISPR/Cas9 and TALEN systems which target Wiskott–Aldrich syndrome (WAS) and tyrosine aminotransferase (TAT) genes [24].